Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-012928
Filing Date
2012-03-05
Accepted
2012-03-05 17:00:03
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v303016_10k.htm 10-K 756677
2 EXHIBIT 23.1 v303016_ex23-1.htm EX-23.1 2295
3 EXHIBIT 31.1 v303016_ex31-1.htm EX-31.1 9439
4 EXHIBIT 31.2 v303016_ex31-2.htm EX-31.2 9513
5 EXHIBIT 32 v303016_ex32.htm EX-32 4811
6 GRAPHIC chart.jpg GRAPHIC 53708
  Complete submission text file 0001144204-12-012928.txt   2451955

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20111231.xml EX-101.INS 234617
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20111231.xsd EX-101.SCH 15472
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20111231_cal.xml EX-101.CAL 30127
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20111231_def.xml EX-101.DEF 92449
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20111231_lab.xml EX-101.LAB 123683
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20111231_pre.xml EX-101.PRE 109848
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 12667320
SIC: 2834 Pharmaceutical Preparations